Healthcare Cold Chain Logistics Market - Global Outlook & Forecast 2023-2028

Description

The global healthcare cold chain logistics market is expected to grow at a CAGR of 5.26% from 2022 to 2028.

MARKET TRENDS

The increasing demand for air ambulances is fueled by growing demand for organ transplants and emergency patient transfer. The demand for air ambulances is growing in the U.S. and Europe; however, it is expected to create lucrative opportunities in APAC and Latin America during the forecast period. The leading healthcare cold chain logistics also raises growing funds to support air ambulances. For instance, Deutsche Post DHL Group raised about USD 95,900 in 2021 for local air ambulance service.

Recently, clinical research has become highly globalized, with many of these studies being conducted across the globe and a significant increase in clinical trials in developing countries. The focus of clinical trial researchers is now shifting from developed markets of Japan, Australia, South Korea, and Singapore to emerging economies such as Thailand, China, the Philippines, and Vietnam.

Major companies strive to offer cloud-based supply chain services and secured supply chain functions such as blockchain technology and live tracking platform as they help healthcare companies safeguard the validity of their products. Vendors in the healthcare cold chain logistics market, such as FedEx and Nippon Express, are focused on developing their pioneering IoT technology to monitor and perform the live tracking of their shipments. These solutions are also expected to prevent the production and distribution of counterfeit drugs. According to DB Schenker, a subsidiary of DB Group, to increase transport density and reliability, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential. In 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group to provide industry-leading digital supply chain IT solutions for cell and gene therapies.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT

The pharmaceuticals product segment dominated the global healthcare cold chain logistics market due to increasing demand for both branded and generic drugs and vaccines. Pharmaceuticals are imported and exported around the world on a massive scale. Aging populations and new drugs to treat rare and specialty diseases fuel this growth. North America and Europe are the major markets for the largest pharmaceutical segment share. About 97% of marketed drugs are classified as small molecules. Biologics will lead among the top-selling products and new sales generators projected for 2022, whereas small molecules will continue to lead in new drug approvals. According to the US FDA's Center for Drug Evaluation and Research, of the 50 new molecular entities (NMEs) approved in 2021, 36 (72%) were small molecules, and 14 (28%) were biologics.

Segmentation by Product

Pharmaceuticals
Medical Products
Others

INSIGHTS BY FUNCTION

The global healthcare cold chain logistics market by service is segmented into transportation, warehousing, and others. As transportation is a crucial part of the logistics chain, it accounted for the highest revenue share of the market. Transportation is the most crucial part of cold chain logistics because the products are transported to the end-user. The demand for temperature-controlled transportation is also rising to maintain the quality of products. Furthermore, road transportation dominates the transportation segment, with a revenue share of over 66% in 2022. The highest share of road transportation can be attributed to its low cost in workforce and operation. In January 2021, over 58% of US-Canada cross-border freight was moved by trucks, followed by rail, with over 16% of cross-border freight.

Segmentation by Service

Transportation
- Road
- Water
- Air
Warehousing
Others

INSIGHTS BY END-USER

The pharmaceutical/biotech companies' end-user segment accounted for the highest revenue share of the global healthcare cold chain logistics market in 2022. Pharmaceutical/biotech companies dominate the end-user segment because this segment is the primary manufacturer of healthcare products that are temperature sensitive and need cold chain logistics to ensure efficient and timely delivery of medications to the patients and to receive raw materials such as APIs to develop several pharmaceutical products. In recent years, it has been noticed that there is growing spending in cold chain logistics that is contributing to market growth. The revenue share of the pharmaceutical/biotech companies' segment is expected to grow faster in APAC during the forecast period as APAC is a potential market for pharma industry growth.

Segmentation by End-User

Pharmaceutical/Biotech Companies
Hospitals & Clinics
Research & Diagnostic Labs
Others

GEOGRAPHICAL ANALYSIS

North America accounted for the highest revenue share of over 37% of the global healthcare cold chain logistics market in 2022. The larger share is contributed by the increasing clinical trial spending, increasing spending on R&D activities to develop new drugs, and the presence of top leading pharmaceutical companies. About five of the ten leading pharmaceutical companies in 2020 were from the United States. In the U.S., branded drugs accounted for around 83.9% of spending in the US alone. In 2020, about 8.1% of global drug and medicine shipments originated from North America. Further, North America and Europe accounted for about 80% of monoclonal antibodies. Thus, the demand for biologics, i.e., vaccines and monoclonal antibodies, is increasing investments in R&D. These are major factors driving the healthcare cold chain logistics market.

Segmentation by Geography

North America
- The U.S.
- Canada
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
APAC
- China
- Japan
- India
- South Korea
- Australia
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa

VENDOR LANDSCAPE

The global healthcare cold chain logistics market is highly fragmented and concentrated, with many key players in the industry. AmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel are the significant players in the global healthcare cold chain logistics market. Vendors are increasingly focusing on integrating new advancements in their services to become more competitive and increase their profit margin. These advancements include integrating blockchain technology to ensure safety and authenticity and avoid counterfeiting drug fraud. Further, several vendors, such as Kuehne+ Nagel, give a fully integrated "live tracking" platform for easy access to data regarding the shipment. In addition, FedEx, a key company, and Nippon Express provide safe and compliant transportation of temperature-sensitive shipments in pharma. Their shipments are enabled with real-time tracking and tracing data.

Key Company Profiles

AmerisourceBergen
DB Group
Deutsche Post DHL Group
CEVA Logistics
United Parcel Service
FedEx
Kuehne + Nagel

Other Prominent Vendors

AWL India
Alloga
A.P. Moller - Maersk
Azenta
Cold Chain Technologies
COREX Logistics
Cardinal Health
DPD
DSV
Farmasoft
GXO Logistics
Kerry Logistics Network
Lufthansa Cargo
Logista
Nippon Express
Noatum Logistics
Phoenix Group
Parexel International
Quick International Courier
SEKO Logistics
SINOTRANS
Yourway
YUSEN LOGISTICS
YSDS

KEY QUESTIONS ANSWERED:

1. How big is the healthcare cold chain logistics market?
2. What is the projected growth rate of the healthcare cold chain logistics market?
3. Who are the key players in the global healthcare cold chain logistics market?
4. What are the growing healthcare cold chain logistics market trends?
5. Which region holds the most significant global healthcare cold chain logistics market share?

Product Code: ARZ230619

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
- 4.3.2 MARKET SEGMENTATION BY PRODUCT
- 4.3.3 MARKET SEGMENTATION BY FUNCTION
- 4.3.4 MARKET SEGMENTATION BY FUNCTION
- 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 MARKET SCENARIO

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 LOGISTICS CONTROL THROUGH INTERNET OF MEDICAL THINGS (IOMT)
9.2 ADOPTION OF BLOCKCHAIN TECHNOLOGY
9.3 EMERGENCE OF DIRECT-TO-PATIENT LOGISTICS SERVICES

10 MARKET GROWTH ENABLERS

10.1 RISE IN NUMBER OF CLINICAL TRIALS
10.2 INCREASING COLLABORATIONS BETWEEN 3PL PROVIDERS & HEALTHCARE PROVIDERS
10.3 SURGE IN DEMAND FOR GENERICS & BIOSIMILARS
10.4 INCREASE IN MASS IMMUNIZATION PROGRAMS

11 MARKET RESTRAINTS

11.1 LACK OF COMPLIANCE & CHANGING REGULATIONS
11.2 GEOPOLITICAL RISKS & FLUCTUATING INTERNATIONAL TRADE REGULATORY POLICIES
11.3 INBOUND LOGISTICS SERVICES FOR MANUFACTURERS

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
- 12.2.1 INSIGHTS BY PRODUCT
- 12.2.2 INSIGHTS BY SERVICE
- 12.2.3 INSIGHTS BY END USER
- 12.2.4 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PHARMACEUTICALS
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
13.4 MEDICAL PRODUCTS
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
13.5 OTHERS
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY

14 SERVICE

14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 TRANSPORTATION
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.3.4 ROAD
- 14.3.5 MARKET OVERVIEW
- 14.3.6 MARKET SIZE & FORECAST
- 14.3.7 WATER
- 14.3.8 MARKET OVERVIEW
- 14.3.9 MARKET SIZE & FORECAST
- 14.3.10 AIR
- 14.3.11 MARKET OVERVIEW
- 14.3.12 MARKET SIZE & FORECAST
14.4 WAREHOUSING
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
14.5 OTHERS
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY

15 END USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 PHARMACEUTICAL/BIOTECHNOLOGY COMPANIES
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 MARKET BY GEOGRAPHY
15.4 HOSPITALS & CLINICS
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 MARKET BY GEOGRAPHY
15.5 RESEARCH & DIAGNOSTIC LABORATORIES
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
- 15.5.3 MARKET BY GEOGRAPHY
15.6 OTHERS
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST
- 15.6.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: PRODUCT
17.4 NORTH AMERICA: SERVICE
17.5 NORTH AMERICA: END USER
17.6 KEY COUNTRIES
- 17.6.1 US: MARKET SIZE & FORECAST
- 17.6.2 CANADA: MARKET SIZE & FORECAST

18 EUROPE

18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: PRODUCT
18.4 EUROPE: SERVICE
18.5 EUROPE: END USER
18.6 KEY COUNTRIES
- 18.6.1 GERMANY: MARKET SIZE & FORECAST
- 18.6.2 FRANCE: MARKET SIZE & FORECAST
- 18.6.3 UK: MARKET SIZE & FORECAST
- 18.6.4 ITALY: MARKET SIZE & FORECAST
- 18.6.5 SPAIN: MARKET SIZE & FORECAST

19 APAC

19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: PRODUCT
19.4 APAC: SERVICE
19.5 APAC: END USER
19.6 KEY COUNTRIES
- 19.6.1 CHINA: MARKET SIZE & FORECAST
- 19.6.2 JAPAN: MARKET SIZE & FORECAST
- 19.6.3 INDIA: MARKET SIZE & FORECAST
- 19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 19.6.5 AUSTRALIA: MARKET SIZE & FORECAST

20 LATIN AMERICA

20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: PRODUCT
20.4 LATIN AMERICA: SERVICE
20.5 LATIN AMERICA: END USER
20.6 KEY COUNTRIES
- 20.6.1 BRAZIL: MARKET SIZE & FORECAST
- 20.6.2 MEXICO: MARKET SIZE & FORECAST
- 20.6.3 ARGENTINA: MARKET SIZE & FORECAST

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: PRODUCT
21.4 MIDDLE EAST & AFRICA: SERVICE
21.5 MIDDLE EAST & AFRICA: END-USER
21.6 KEY COUNTRIES
- 21.6.1 TURKEY: MARKET SIZE & FORECAST
- 21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW
- 22.1.1 AMERISOURCEBERGEN
- 22.1.2 DB GROUP
- 22.1.3 DEUTSCHE POST DHL
- 22.1.4 CEVA LOGISTICS
- 22.1.5 UNITED PARCEL SERVICE
- 22.1.6 FEDEX
- 22.1.7 KUEHNE+NAGEL

23 KEY COMPANY PROFILES

23.1 AMERISOURCEBERGEN
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 SERVICE OFFERINGS
- 23.1.3 KEY STRATEGIES
- 23.1.4 KEY STRENGTHS
- 23.1.5 KEY OPPORTUNITIES
23.2 DB GROUP
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 SERVICE OFFERINGS
- 23.2.3 KEY STRATEGIES
- 23.2.4 KEY STRENGTHS
- 23.2.5 KEY OPPORTUNITIES
23.3 DEUTSCHE POST DHL GROUP
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 SERVICE OFFERINGS
- 23.3.3 KEY STRATEGIES
- 23.3.4 KEY STRENGTHS
- 23.3.5 KEY OPPORTUNITIES
23.4 CEVA LOGISTICS
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 SERVICE OFFERINGS
- 23.4.3 KEY STRATEGIES
- 23.4.4 KEY STRENGTHS
- 23.4.5 KEY OPPORTUNITIES
23.5 UNITED PARCEL SERVICE
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 SERVICE OFFERINGS
- 23.5.3 KEY STRATEGIES
- 23.5.4 KEY STRENGTHS
- 23.5.5 KEY OPPORTUNITIES
23.6 FEDEX
- 23.6.1 BUSINESS OVERVIEW
- 23.6.2 SERVICE OFFERINGS
- 23.6.3 KEY STRATEGIES
- 23.6.4 KEY STRENGTHS
- 23.6.5 KEY OPPORTUNITIES
23.7 KUEHNE + NAGEL
- 23.7.1 BUSINESS OVERVIEW
- 23.7.2 SERVICE OFFERINGS
- 23.7.3 KEY STRATEGIES
- 23.7.4 KEY STRENGTHS
- 23.7.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

24.1 AWL INDIA
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 SERVICE OFFERINGS
24.2 ALLOGA
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 SERVICE OFFERINGS
24.3 A.P. MOLLER - MAERSK
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 SERVICE OFFERINGS
24.4 AZENTA
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
24.5 COLD CHAIN TECHNOLOGIES
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 SERVICE OFFERINGS
24.6 COREX LOGISTICS
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 SERVICE OFFERINGS
24.7 CARDINAL HEALTH
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 SERVICE OFFERINGS
24.8 DPD
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 SERVICE OFFERINGS
24.9 DSV
- 24.9.1 BUSINESS OVERVIEW
- 24.9.2 SERVICE OFFERINGS
24.10 FARMASOFT
- 24.10.1 BUSINESS OVERVIEW
- 24.10.2 SERVICE OFFERINGS
24.11 GXO LOGISTICS
- 24.11.1 BUSINESS OVERVIEW
- 24.11.2 SERVICE OFFERINGS
24.12 KERRY LOGISTICS NETWORK
- 24.12.1 BUSINESS OVERVIEW
- 24.12.2 PRODUCT OFFERINGS
24.13 LUFTHANSA CARGO
- 24.13.1 BUSINESS OVERVIEW
- 24.13.2 SERVICE OFFERINGS
24.14 LOGISTA
- 24.14.1 BUSINESS OVERVIEW
- 24.14.2 PRODUCT OFFERINGS
24.15 NIPPON EXPRESS
- 24.15.1 BUSINESS OVERVIEW
- 24.15.2 SERVICE OFFERINGS
24.16 NOATUM LOGISTICS
- 24.16.1 BUSINESS OVERVIEW
- 24.16.2 SERVICE OFFERINGS
24.17 PHOENIX GROUP
- 24.17.1 BUSINESS OVERVIEW
- 24.17.2 SERVICE OFFERINGS
24.18 PAREXEL INTERNATIONAL
- 24.18.1 BUSINESS OVERVIEW
- 24.18.2 SERVICE OFFERINGS
24.19 QUICK INTERNATIONAL COURIER
- 24.19.1 BUSINESS OVERVIEW
- 24.19.2 PRODUCT OFFERINGS
24.20 SEKO LOGISTICS
- 24.20.1 BUSINESS OVERVIEW
- 24.20.2 SERVICE OFFERINGS
24.21 SINOTRANS
- 24.21.1 BUSINESS OVERVIEW
- 24.21.2 SERVICE OFFERINGS
24.22 YOURWAY
- 24.22.1 BUSINESS OVERVIEW
- 24.22.2 SERVICE OFFERINGS
24.23 YUSEN LOGISTICS
- 24.23.1 BUSINESS OVERVIEW
- 24.23.2 SERVICE OFFERINGS
24.24 YSDS
- 24.24.1 BUSINESS OVERVIEW
- 24.24.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY PRODUCT
26.3 MARKET BY SERVICE
26.4 MARKET BY END USER
26.5 NORTH AMERICA BY PRODUCT
26.6 NORTH AMERICA BY SERVICE
26.7 NORTH AMERICA BY END USER
26.8 EUROPE BY PRODUCT
26.9 EUROPE BY SERVICE
26.10 EUROPE BY END USER
26.11 APAC BY PRODUCT
26.12 APAC BY SERVICE
26.13 APAC BY END USER
26.14 LATIN AMERICA BY PRODUCT
26.15 LATIN AMERICA BY SERVICE
26.16 LATIN AMERICA BY END USER
26.17 MIDDLE EAST AND AFRICA BY PRODUCT
26.18 MIDDLE EAST AND AFRICA BY SERVICE
26.19 MIDDLE EAST AND AFRICA BY END USER

27 APPENDIX

27.1 ABBREVIATIONS